retatrutide type 2 diabetes phase 2 weight loss 2024 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released trial results demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide Shows Strong Weight Loss

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide [J]

Heres how they differ and what extra things they may offer: GIP enhances insulin secretion after eating and may improve fat metabolism (helping the body use or store fat differently)

A Washington state study found that tesamorelin helps lower levels of myo-inositol (MI), an osmolyte linked to early-onset Alzheimer's disease [10]

Preterm infants are not efficient in their energy use, a poor exogenous nutrient supply during the first few days of life may not only lead to extrauterine growth retardation in newborns, but it may also increase their susceptibility to infectious diseases and organ function damage (80)

Silymarin actions reduced the frequency of spontaneous contractions, their amplitude, and AUC and also prolonged the intervals between contractions

00:12:12 Vickie Danaher Lets close out this topic now with a few other key pearls that we can bring back to our pharmacies